I agree that this site is using cookies. You can find further informations here.
X
Morales Murilo, Serafin
72  results:
Search for persons X
?
1

A Phase I/II Study of GSK525762 Combined with Fulvestrant i..:

Cescon, David W. ; Hilton, John ; Morales Murilo, Serafin...
Clinical Cancer Research.  30 (2023)  2 - p. 334-343 , 2023
Link: https://doi.org/10.1158/..
 
?
2

A Phase I/II Study of GSK525762 Combined with Fulvestrant i..:

Cescon, David W ; Hilton, John ; Morales Murilo, Serafin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792358/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
3

Supplementary Data1 from A Phase I/II Study of GSK525762 Co..:

David W. Cescon ; John Hilton ; Serafin Morales Murilo...
doi:10.1158/1078-0432.25011392.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
4

Supplementary Data1 from A Phase I/II Study of GSK525762 Co..:

David W. Cescon ; John Hilton ; Serafin Morales Murilo...
doi:10.1158/1078-0432.25011392.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
5

Selection of neoadjuvant treatment based on the 21-GENE tes..:

Morales Murillo, Serafin ; Gasol Cudos, Ariadna ; Veas Rodriguez, Joel...
The Breast.  56 (2021)  - p. 35-41 , 2021
Link: https://doi.org/10.1016/..
 
?
6

A phase II study of combined ridaforolimus and dalotuzumab ..:

Baselga, José ; Morales, Serafin M. ; Awada, Ahmad...
Breast Cancer Research and Treatment.  163 (2017)  3 - p. 535-544 , 2017
Link: https://doi.org/10.1007/..
 
?
7

A randomized phase II trial of ridaforolimus, dalotuzumab, ..:

Rugo, Hope S. ; Trédan, Olivier ; Ro, Jungsil...
Breast Cancer Research and Treatment.  165 (2017)  3 - p. 601-609 , 2017
Link: https://doi.org/10.1007/..
 
?
8

Single-agent metronomic versus weekly oral vinorelbine as f..:

Freyer, Gilles ; Martinez-Jañez, Noelia ; Kukielka-Budny, Bożena...
The Breast.  74 (2024)  - p. 103681 , 2024
Link: https://doi.org/10.1016/..
 
?
9

XENERA-1: a randomised double-blind Phase II trial of xentu..:

Schmid, Peter ; Cortes, Javier ; Joaquim, Ana...
Breast Cancer Research.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

Applications of CRISPR Technology to Breast Cancer and Trip..:

Pont, Mariona ; Marqués, Marta ; Sorolla, Maria Alba...
Cancers.  15 (2023)  17 - p. 4364 , 2023
Link: https://doi.org/10.3390/..
 
?
11

Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathologica..:

Ocaña, Alberto ; Chacón, Jose Ignacio ; Calvo, Lourdes...
Frontiers in Oncology.  11 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Are Transcription Factors Plausible Oncotargets for Triple ..:

Marqués, Marta ; Sorolla, Maria Alba ; Urdanibia, Izaskun...
Cancers.  14 (2022)  5 - p. 1101 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Overall survival with palbociclib plus endocrine therapy ve..:

Martín, Miguel ; Zielinski, Christoph ; Ruiz-Borrego, Manuel...
European Journal of Cancer.  168 (2022)  - p. 12-24 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Health-related quality of life with palbociclib plus endocr..:

Kahan, Zsuzsanna ; Gil-Gil, Miguel ; Ruiz-Borrego, Manuel...
European Journal of Cancer.  156 (2021)  - p. 70-82 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Her2-Positive Cancers and Antibody-Based Treatment: State o..:

Morales, Serafin ; Gasol, Ariadna ; Sanchez, Douglas Rene
Cancers.  13 (2021)  22 - p. 5771 , 2021
Link: https://doi.org/10.3390/..
 
1-15